Distinct Prognostic Value of Circulating Anti-Telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0531-5